Was wurde eigentlich aus Prialt®?: Beobachtungsstudie über den Langzeiteinsatz von Ziconotid in der Behandlung chronischer Schmerzen

BACKGROUND: Prialt® was approved by the European Medicine Agency in February 2005. Besides morphine, it is the only analgesic approved for long-term intrathecal infusion in the treatment of chronic pain. As it does not bind to opioid receptors, its use in the treatment of chronic pain seemed to be s...

Descripción completa

Detalles Bibliográficos
Autores principales: Löschner, Denise, Dries, Rebecca, Kalff, Rolf, Walter, Jan, Reichart, Rupert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Originalien
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452570/
https://www.ncbi.nlm.nih.gov/pubmed/33507370
http://dx.doi.org/10.1007/s00482-021-00531-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452570/
https://www.ncbi.nlm.nih.gov/pubmed/33507370
http://dx.doi.org/10.1007/s00482-021-00531-y

Ejemplares similares